Elevance Health, Inc. 10-Q

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES Issuer Purchases of Equity Securities The following table presents information related to our repurchases of common stock for the periods indicated: Period Total Number of Shares Purchased 1 Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Programs 2 Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs (in millions, except share and per share data) July 1, 2023 to July 31, 2023 502,279 $ 442.38 500,755 $ 5,386 August 1, 2023 to August 31, 2023 386,749 $ 464.83 385,456 5,207 September 1, 2023 to September 30, 2023 176,840 449.35 176,309 5,128 1,065,868 1,062,520 1 Total number of shares purchased includes 3,348 shares delivered to or withheld by us in connection with employee payroll tax withholding upon the exercise or vesting of stock awards. Stock grants to employees and directors and stock issued for stock option plans and stock purchase plans in the consolidated changes in equity are shown net of these shares purchased. 2 Represents the number of shares repurchased through the common stock repurchase program authorized by our Board of Directors, which the Board of Directors evaluates periodically. During the three months ended September 30, 2023, we repurchased 1,062,520 shares at a total cost of $480 under the program, including the cost of options to purchase shares. The Board of Directors has authorized our common stock repurchase program since 2003. The most recent authorized increase to the program was $5,000 on January 24, 2023 by our Audit Committee, pursuant to authorization granted by the Board of Directors. No duration has been placed on our common stock repurchase program, and we reserve the right to discontinue the program at any time. ITEM 3. DEFAULTS UPON SENIOR SECURITIES None. ITEM 4. MINE SAFETY DISCLOSURES None.